Evolus (EOLS) Operating Income (2017 - 2026)
Evolus (EOLS) reported Operating Income of -$6.8 million for Q1 2026, up 54.86% on a YoY basis from -$4.4 million in Q1 2025, and down 262.27% quarter-over-quarter from $4.2 million in Q4 2025.
Evolus (EOLS) Operating Income (2017 - 2026) Analysis & Trends
Evolus has reported Operating Income for 10 years, with the latest figure at -$6.8 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income rose 54.86% year-over-year to -$6.8 million; the trailing twelve-month figure through Mar 2026 stood at -$24.3 million (up 40.14% YoY), and the FY2025 full-year result was -$32.7 million, up 5.08% from the prior year.
- Operating Income for Q1 2026 stood at -$6.8 million, down from $4.2 million in the prior quarter.
- The five-year high for Operating Income was $4.2 million in Q4 2025, with the low at -$21.3 million in Q2 2022.
- Historically, Operating Income has averaged -$11.1 million across 5 years, with a median of -$11.5 million in 2025.
- Annual changes were most pronounced in 2022 — Operating Income sank 292.47% — and 2025, when it surged 282.37%.
- Evolus' Operating Income stood at -$10.6 million in 2022, then rose by 18.82% to -$8.6 million in 2023, then soared by 73.2% to -$2.3 million in 2024, then surged by 282.37% to $4.2 million in 2025, then slumped by 262.27% to -$6.8 million in 2026.
- The last three Operating Income figures came in at -$6.8 million (Q1 2026), $4.2 million (Q4 2025), and -$11.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 14.03 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 193.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -48.28 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -78.32 Mn |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | -6.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.85 Mn |
| Dec 31, 2025 | 4.22 Mn |
| Sep 30, 2025 | -11.50 Mn |
| Jun 30, 2025 | -10.21 Mn |
| Mar 31, 2025 | -15.17 Mn |
| Dec 31, 2024 | -2.31 Mn |
| Sep 30, 2024 | -15.47 Mn |
| Jun 30, 2024 | -7.70 Mn |
| Mar 31, 2024 | -8.92 Mn |
| Dec 31, 2023 | -8.64 Mn |
| Sep 30, 2023 | -13.44 Mn |
| Jun 30, 2023 | -15.12 Mn |
| Mar 31, 2023 | -12.04 Mn |
| Dec 31, 2022 | -10.64 Mn |
| Sep 30, 2022 | -17.90 Mn |
| Jun 30, 2022 | -21.35 Mn |
| Mar 31, 2022 | -15.45 Mn |
| Dec 31, 2021 | -18.03 Mn |
| Sep 30, 2021 | -19.11 Mn |
| Jun 30, 2021 | -15.29 Mn |